JAMA Oncology Publication Demonstrates EndoPredict® (EPClin) Significantly Outperforms Oncotype DX® Recurrence Score in Early-Stage Breast Cancer

World News: . []

SALT LAKE CITY Feb 15 2018 GLOBE NEWSWIRE -- Myriad LINK  Inc NASDAQMYGN today announced that a comparative analysis of commercially LINK  prognostic breast cancer tests in LINK  with early-stage breast cancer has been LINK  d in ....

More news and information about Myriad Genetics, Inc.

Published By:

Globe Newswire: 16:15 GMT Thursday 15th February 2018

Published: .

Search for other references to "jama" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us